CN113845582A - 内源性多肽在制备预防或治疗子宫内膜癌靶向药物中的应用 - Google Patents
内源性多肽在制备预防或治疗子宫内膜癌靶向药物中的应用 Download PDFInfo
- Publication number
- CN113845582A CN113845582A CN202111206972.2A CN202111206972A CN113845582A CN 113845582 A CN113845582 A CN 113845582A CN 202111206972 A CN202111206972 A CN 202111206972A CN 113845582 A CN113845582 A CN 113845582A
- Authority
- CN
- China
- Prior art keywords
- endometrial cancer
- polypeptide
- ecdp2
- endogenous
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
子宫内膜癌(n=6) | 良性病变(n=6) | ||
年龄 | 54.5±5.5 | 53.5±8.5 | p>0.05 |
BMI | 23.4±1.2 | 23.1±4.1 | p>0.05 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111206972.2A CN113845582B (zh) | 2021-10-15 | 2021-10-15 | 内源性多肽在制备预防或治疗子宫内膜癌靶向药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111206972.2A CN113845582B (zh) | 2021-10-15 | 2021-10-15 | 内源性多肽在制备预防或治疗子宫内膜癌靶向药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113845582A true CN113845582A (zh) | 2021-12-28 |
CN113845582B CN113845582B (zh) | 2022-05-27 |
Family
ID=78978679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111206972.2A Active CN113845582B (zh) | 2021-10-15 | 2021-10-15 | 内源性多肽在制备预防或治疗子宫内膜癌靶向药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113845582B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115232199A (zh) * | 2022-09-23 | 2022-10-25 | 南京市妇幼保健院 | 一种内源性多肽的筛选方法及其筛选的多肽的应用 |
CN117801091A (zh) * | 2023-12-28 | 2024-04-02 | 广东圆康再生医学科技开发有限公司 | 一种子宫内膜干细胞在子宫内膜修复中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060258583A1 (en) * | 2003-08-29 | 2006-11-16 | Children's Medical Center Corporation | Anti-angiogenic peptides for treating or preventing endometriosis |
WO2017079430A1 (en) * | 2015-11-03 | 2017-05-11 | Bioincept, Llc | Peptides and methods of treating endometriosis using the same |
CN112675289A (zh) * | 2021-01-07 | 2021-04-20 | 黑龙江中医药大学 | 短肽Asp-His-Tyr在制备治疗子宫内膜异位症的药物中的应用 |
-
2021
- 2021-10-15 CN CN202111206972.2A patent/CN113845582B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060258583A1 (en) * | 2003-08-29 | 2006-11-16 | Children's Medical Center Corporation | Anti-angiogenic peptides for treating or preventing endometriosis |
WO2017079430A1 (en) * | 2015-11-03 | 2017-05-11 | Bioincept, Llc | Peptides and methods of treating endometriosis using the same |
CN112675289A (zh) * | 2021-01-07 | 2021-04-20 | 黑龙江中医药大学 | 短肽Asp-His-Tyr在制备治疗子宫内膜异位症的药物中的应用 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115232199A (zh) * | 2022-09-23 | 2022-10-25 | 南京市妇幼保健院 | 一种内源性多肽的筛选方法及其筛选的多肽的应用 |
CN117801091A (zh) * | 2023-12-28 | 2024-04-02 | 广东圆康再生医学科技开发有限公司 | 一种子宫内膜干细胞在子宫内膜修复中的应用 |
CN117801091B (zh) * | 2023-12-28 | 2024-05-31 | 广东圆康再生医学科技开发有限公司 | 一种子宫内膜干细胞在子宫内膜修复中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN113845582B (zh) | 2022-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113845582B (zh) | 内源性多肽在制备预防或治疗子宫内膜癌靶向药物中的应用 | |
CN109678987A (zh) | 一种硫化氢释放剂ha-adt、其制备方法及应用 | |
CN101314793A (zh) | 卵巢癌的检测方法及抑制方法 | |
CN107419004A (zh) | lncRNA‑RP11‑290F20.3及其小干扰RNA的应用 | |
CN109680064A (zh) | Ythdf2基因在尿路上皮癌诊断、预防和治疗中的应用 | |
CN114129734A (zh) | 一种胆组织靶向载药外泌体及其制备方法和应用 | |
CN108277279A (zh) | 一种lncRNA在诊断和/或治疗乳腺癌中的应用 | |
CN110229901A (zh) | 与三阴性乳腺癌诊疗相关的基因hsa_circ_0027089及其应用 | |
CN112656808A (zh) | 一种肝素寡糖在制备抗肿瘤药物中的应用 | |
CN108329381A (zh) | 一种来源于麒麟菜的十六肽及其在制备防治恶性肿瘤转移药物中的应用 | |
CN104788391B (zh) | 肉桂酰中性红酰胺(ca‑pz)及其制备与应用 | |
CN114934115A (zh) | Gmfb蛋白作为肾透明细胞癌生物学标志的应用 | |
CN107144695A (zh) | Arl13b蛋白在癌症诊断中的应用 | |
CN112716947A (zh) | 从骆驼蓬中提取分离的γ-去氢骆驼蓬碱在制备抑制胃癌药物中的应用 | |
WO2020168741A1 (zh) | 卡格列净在制备抗肿瘤药物中的应用 | |
CN110257522A (zh) | 与乳腺癌诊疗相关的基因hsa_circ_0045881及其应用 | |
CN112190710A (zh) | 脂源性多肽在制备转移性乳腺癌靶向药物中的应用 | |
CN116239654A (zh) | 一种内源性多肽ecdp4及其应用 | |
CN115232199B (zh) | 一种内源性多肽的筛选方法及其筛选的多肽的应用 | |
CN114288410B (zh) | Src抑制剂和fak抑制剂在制备用于抑制肺癌转移的药物中的应用 | |
CN115505022B (zh) | 一种生物碱苷及其应用 | |
CN113122627B (zh) | Igfl4基因作为标志物在卵巢癌中诊断及治疗的应用 | |
CN110042160B (zh) | 一种消化系统恶性肿瘤标志物及其制备抑制消化系统恶性肿瘤药物的方法 | |
CN110760518B (zh) | 分子标志物penk及其在三阴性乳腺癌药物中的应用 | |
CN116855469A (zh) | 脂肪分泌肽masp5及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Ruan Hongjie Inventor after: Inch cloud flower Inventor after: Wang Luyao Inventor after: Fu Ziyi Inventor after: Bushalam Muha buy Inventor after: Hu Shuang Inventor after: Chen Jin Inventor after: Jia Xuemei Inventor before: Ruan Hongjie Inventor before: Inch cloud flower Inventor before: Wang Luyao Inventor before: Fu Ziyi Inventor before: Bushalam Muha buy Inventor before: Hu Shuang |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |